Role of C-reactive protein in cardiovascular disease - Wikidata - awgldk - TriplyDB

Role of C-reactive protein in cardiovascular disease

Role of C-reactive protein in cardiovascular disease

http://www.wikidata.org/entity/Q28166927

about

C-reactive protein (CRP)-lowering agents Optimal lipid modification: the rationale for combination therapy Obesity and inflammation: the linking mechanism and the complications Two Valid Measures of Self-rated Physical Activity and Capacity.Fibrates: what have we learned in the past 40 years?New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor.Impact of off-pump coronary artery bypass surgery on systemic inflammation: current best available evidence.The relationship between serum levels of hs-CRP and coronary lesion severity New evidence for nicotinic acid treatment to reduce atherosclerosis.The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction.Relationship between echocardiographic findings and laboratory serum biomarkers in patients with and without low cardiac output.High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension.Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women.Retinol-binding protein, transthyretin, and C-reactive protein in extremely low birth weight (ELBW) infants.Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats.

P2860

Q28200344-766CFBEF-B2F1-4D55-8FE5-A65CD3C6B6F6 Q28219266-BAB3B365-5CAC-4721-B188-7E590A5F4D2A Q33897331-88F2AD22-BEC0-4CD3-9319-53D2EC34C834 Q36550878-92D7E6B0-57ED-4911-8753-75AC290AE2DE Q36742410-D7A94F31-F108-4A3F-A796-A919EE3253A3 Q36897456-EA894CEE-6B5D-4161-A655-7B5D7C47246D Q36930957-4D582C29-8E23-4D4B-8358-441A20D96308 Q37187825-DC09CF50-4705-4E4E-9367-A3CF3C557333 Q37799365-8E52C894-CA2E-46BE-8EEA-0BF3E7397ECE Q38306411-0B0AA314-B334-4E4E-BC69-E865728724D8 Q41964271-680F497B-017B-48C7-A80C-2A32B39C517A Q43087849-991F50C8-2FE1-4675-9645-385DD8D9E0E5 Q46560125-FE62FF3A-E5AF-4F6E-BB8D-149769B74C26 Q46738580-491C5E99-FBC7-44CA-879E-D35653E55518 Q48612010-E65022C0-4CFA-4D5A-97F3-EC49750B1E9E

P2860

Role of C-reactive protein in cardiovascular disease

http://www.wikidata.org/entity/Q28166927

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Role of C-reactive protein in cardiovascular disease

@ast

Role of C-reactive protein in cardiovascular disease

@en

Role of C-reactive protein in cardiovascular disease

@nl

type

label

Role of C-reactive protein in cardiovascular disease

@ast

Role of C-reactive protein in cardiovascular disease

@en

Role of C-reactive protein in cardiovascular disease

@nl

prefLabel

Role of C-reactive protein in cardiovascular disease

@ast

Role of C-reactive protein in cardiovascular disease

@en

Role of C-reactive protein in cardiovascular disease

@nl

P1433

Q28166927-43592F60-449D-4216-ACE3-C7C7ACD530E6

P1476

Q28166927-A26DBE7B-CF35-4303-B890-8EA0C2CB460A

P2093

Q28166927-1C01AAC9-17AD-4951-B7DA-3277D7910942

Q28166927-6A700E74-1A10-4C9C-98F7-589D95BDE51D

Q28166927-F9348928-5B53-42AC-AD50-3A17813E6F50

P2860

Q28166927-030A487F-998A-401D-89DC-204F7A1E3570

Q28166927-04899811-3691-441C-91E7-44DCF4E20077

Q28166927-0EB80D78-444E-4480-9187-ECBCEF292972

Q28166927-13BA9CB7-22F6-416A-8547-36116B1492B4

Q28166927-14FDCFC6-3BBC-4940-8B55-2B9CA730FCF1

Q28166927-1803BC82-C445-493F-A213-AFE6AEC881A1

Q28166927-1A11E40D-FC6C-40E3-BECC-A3BAC32E4A74

Q28166927-1D10EDD7-9DF3-48A7-AF83-42407F6531DE

Q28166927-2157731D-4B97-4592-B77E-29344174E3CA

Q28166927-22CE563F-CEFA-4105-AEEE-31F8F8DAA2EC

P304

Q28166927-6403CBFD-B1BF-4FA7-BE89-07149152906F

P31

Q28166927-78BC00D6-707E-46B9-A5BB-5BA2B47D919F

P3181

Q28166927-6BA872F5-4E71-45C5-BED6-E89093646D59

P356

Q28166927-077C16AF-0865-46A2-A155-7B81F4F124A9

P407

Q28166927-60A8B12D-AED8-42E8-81E6-3A6C9F57C6AD

P433

Q28166927-A635F67F-C4FF-4325-AA13-94185A836243

P478

Q28166927-9788082D-5A40-4ABA-88F6-7FE916EF7558

P577

Q28166927-0DF74A71-6E65-4057-A20F-26EF53C79A04

P698

Q28166927-B7FA3D12-2F03-4095-9079-265923342757

P921

Q28166927-9B23191F-52B3-4798-B6E6-7EB81A4B4275

P3181

P356

P1433

Annals of Pharmacotherapy

P1476

Role of C-reactive protein in cardiovascular disease

@en

P2093

James M Backes

http://www.w3.org/2001/XMLSchema#string

Patricia A Howard

http://www.w3.org/2001/XMLSchema#string

Patrick M Moriarty

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect.

P304

110-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4249469

http://www.w3.org/2001/XMLSchema#string

P356

10.1345/APH.1D203

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14742804

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease